Medication info
Kukje Rozaartan 50 mg (Losartan Potassium)

Kukje Rozaartan 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Kukje Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200500391 · Notified 2005.05.24 · Insurance code 643700150

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when it is administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger; for elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective circulating blood volume For patients who may have decreased effective circulating blood volume (intravascular volume depletion) (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
2) Pediatric patients and adolescents aged 6 years and older (1) Patients weighing at least 20 kg but less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Pediatric patients under 6 years of age: Not recommended. (3) Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. (3) Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Kukje Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in type 2 diabetes patients
View approved original text

This medication is used to treat hypertension, and it also helps prevent and treat kidney disease in patients with type 2 diabetes, particularly those with hypertension. It is useful for effectively managing high blood pressure to protect heart and kidney health.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when it is administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger; for elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective circulating blood volume For patients who may have decreased effective circulating blood volume (intravascular volume depletion) (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

2) Pediatric patients and adolescents aged 6 years and older (1) Patients weighing at least 20 kg but less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Pediatric patients under 6 years of age: Not recommended. (3) Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. (3) Pediatric patients with hepatic impairment: Not recommended.

Precautions

This drug can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so use should be discontinued immediately if pregnancy is confirmed. It is safest for women who may become pregnant to avoid taking this medication, and it is advised that pregnant women refrain from use for the health of the fetus. This medication should not be administered to patients with certain conditions, such as severe liver impairment, hereditary angioedema, or primary hyperaldosteronism. Patients with genetic issues such as lactose intolerance should also avoid this medication. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, or valvular heart disease should use this drug cautiously, considering the risk of heart and cerebrovascular issues due to blood pressure reduction. As this medication lowers blood pressure, special care is required for patients with reduced intravascular blood volume or severely impaired kidney function. While taking this medication, various adverse reactions may occur, with common symptoms including dizziness, muscle cramps, back pain, cough, and indigestion. Rarely, serious side effects such as angioedema or liver dysfunction, and rhabdomyolysis may occur, so immediate consultation with a physician is necessary if abnormal symptoms appear. The risk of side effects like hyperkalemia may increase when this medication is taken in conjunction with other antihypertensives or potassium-sparing diuretics, so caution is advised with co-administration. Potassium supplements or salt substitutes containing potassium should not be taken without consulting a physician. Regular monitoring of blood pressure, kidney function, and electrolyte levels during treatment is important to check for abnormalities. This medication is not recommended for breastfeeding women, and breastfeeding should be discontinued if necessary. In case of overdose, hypotension and tachycardia may occur, and prompt treatment in a hospital setting is required. Finally, this medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • lumbago
  • leg pain
  • dizziness
  • congestion
Show 132 more
  • upper respiratory tract infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • hypersensitivity
  • paresthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitive reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning sensation
  • eye pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • urinary frequency
  • urethral infection
  • dry cough
  • soft tissue infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • erythema multiforme
  • hyponatremia
  • ALT elevation
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beat
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is also advisable to keep it in a cool, dry place, maintaining a temperature between 15 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.